DESIGN OF THE SILENT CEREBRAL INFARCT TRANSFUSION (SIT) TRIAL

BACKGROUND: Silent cerebral infarct (SCI) is the most common cause of serious neurological disease in sickle cell anemia (SCA), affecting approximately 22% of children. The goal of this trial is to determine whether blood transfusion therapy will reduce further neurological morbidity in children wit...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Pediatr Hematol Oncol
Prif Awduron: Casella, James F., King, Allison A., Barton, Bruce, White, Desiree A., Noetzel, Michael J., Ichord, Rebecca N., Terrill, Cindy, Hirtz, Deborah, McKinstry, Robert C., Strouse, John J., Howard, Thomas H., Coates, Thomas D., Minniti, Caterina P, Campbell, Andrew D., Vendt, Bruce A., Lehmann, Harold, DeBaun, Michael R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572477/
https://ncbi.nlm.nih.gov/pubmed/20201689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/08880010903360367
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg